Discover investment opportunities in Stocks Less Than 50 Cents using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Stocks Less Than 50 Cents using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Stocks Less Than 50 Cents using our Smart AI Filter.
8 stocks found for "Stocks Less Than 50 Cents"
Security name | Expected returns | Sharpe Ratio | Beta | Volatility | P/E Ratio | Dividend Yield |
|---|---|---|---|---|---|---|
1.26 Risk measure | ±91.1% Price volatility | -0.4 Valuation | 0.00% Annual yield | |||
1.43 Risk measure | ±75.7% Price volatility | -0.7 Valuation | 0.00% Annual yield | |||
0.45 Risk measure | ±100.0% Price volatility | -0.4 Valuation | 0.00% Annual yield | |||
0.54 Risk measure | ±86.5% Price volatility | -1.3 Valuation | 0.00% Annual yield | |||
0.50 Risk measure | ±100.0% Price volatility | — Valuation | 0.00% Annual yield | |||
0.10 Risk measure | ±100.0% Price volatility | -1.9 Valuation | 0.00% Annual yield | |||
2.07 Risk measure | ±100.0% Price volatility | -4.2 Valuation | 0.00% Annual yield | |||
0.59 Risk measure | ±100.0% Price volatility | -0.1 Valuation | 0.00% Annual yield |
This search uses our Smart AI Filter to identify stocks matching your criteria. Results are ranked by relevance and include key financial metrics to help you make informed investment decisions.
Get personalized stock recommendations, save custom screens, and access premium filters. All our screening tools are free—signing up gives you more personalized results and the ability to save your research.
Compliance disclosure:
The securities listed on this website have not paid to be included in the results. The inclusion of any securities in the results shown does not imply any relationship with PortfolioPilot. The order of the results is ranked based on the Sharpe Ratio, which is a measure of risk-adjusted return. Please note that these listings are not recommendations or financial advice. Past performance is not indicative of future results.
Dragonfly Energy Holdings Corp. (DFLI) came out with a quarterly loss of $0.58 per share versus the Zacks Consensus Estimate of a loss of $1.29. This compares to a loss of $1.98 per share a year ago.
Read moreWe are initiating coverage of Adaptimmune Therapeutics plc ADAP with a 12-month price target of $3.00, translating into sizeable upside from the stock's current price. Adaptimmune designs, develops, manufactures, and delivers innovative cell therapies via the company's unique T-cell receptor (TCR) platform to treat cancers across multiple solid tumor types.
Read moreThe headline numbers for urban-gro, Inc. (UGRO) give insight into how the company performed in the quarter ended September 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Read moreQ: How does the low stock price of DFLI influence investor perception of volatility?
A: Stocks priced under 50 cents, like DFLI, can often be more volatile due to smaller market capitalizations and lower trading volumes. This volatility can stem from speculative trading, making them riskier than higher-priced stocks.
Q: What should an investor consider when looking at PSTV for growth potential?
A: PSTV's appeal may lie in potential growth due to engaging in sectors like biotechnology. However, historical performance, funding, and operational scalability should be reviewed to evaluate growth potential.
Q: Are there specific economic cycles in which TPIC tends to perform better?
A: TPIC, focused on renewable energy, might perform better during cycles of increased environmental regulations and subsidies. Performance can depend on global energy policies and market demand for sustainable solutions.
Q: What sector does ADAP compete in, and what are the associated risks?
A: ADAP operates in the biotech sector, facing risks including regulatory hurdles, extensive R&D costs, and potential for failed drug trials. Investors should consider these when evaluating risk.
Q: How does SENS' technology positioning impact its growth outlook?
A: SENS operates in the medical devices space, benefiting from innovation in glucose monitoring. Technological advancement and market adoption rates are critical to its growth outlook.
Q: What makes ABP attractive for a dividend-focused investor?
A: ABP's dividend appeal requires review of its yield, payout ratio, and historical consistency. Though less typical in low-priced stocks, stable dividends can signify financial health.